9Dyck P J, Kratz K M, Karnes J L, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population based Cohort: the Rochester Diabetic Neuropathy Study[J]. Neurology, 1993,43 (11):2345.
2Bustillo J R. Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical up-date [J]. Dialogues Clin Neurosci, 2013,15 (3) : 329-337.
3Thompson J, Lawrentschuk N, Frydenberg M, et al. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer[J]. BJU Int,2013,112(2):6-20.
5Rivera E J, Goldin A, Fulmer N, et al. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine[J]. J Alzheimers Dis, 2005,8 (3) : 247-268.
6Zimmerman R A. Wang Z. Proton magnetic resonance spectroscopy[J]. Crit Rev Neurosurg, 1999,9(3) : 161-166.
7Huang Y, Chen W, Li Y, et al. Effects of antidepressant treatment on N-acetylaspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using ^1H magnetic resonance spectroscopy[J]. Psychiatry Res,2010,182(1) :48-52.
8van Harten B, de Leeuw FE, Weirtstein HC, et al. Brain imaging in patients with diabetes : a systematic review [ J ]. Diabetes Care, 2006, 29 ( 11 ) :2539-2548.
9Wessels AM, Rombouts SA, Remijnse PL, et al. Cognitive perform- ance in type 1 diabetes patients is associated with cerebral white mat- ter volume [ J ]. Diabetologia, 2007,50 ( 8 ) : 1763-1769.
10Liu I-IS, Chou MC, Chtmg HW, et al. A proton MR spectroscopy and diffusion-tensor imaging study[J]. Radiology, 2011,260(2) :531-540.
